US 10900041
Antisense oligonucleotides for use in treating Alzheimer's disease
granted A61KA61K31/713
Quick answer
US patent 10900041 (Antisense oligonucleotides for use in treating Alzheimer's disease) held by ProQR Therapeutics II B.V. expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ProQR Therapeutics II B.V.
- Grant date
- Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/713